Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 123

1.
2.

Inhibition of breast carcinoma and trophoblast cell invasiveness by vascular endothelial growth factor.

Fitzpatrick TE, Lash GE, Yanaihara A, Charnock-Jones DS, Macdonald-Goodfellow SK, Graham CH.

Exp Cell Res. 2003 Feb 15;283(2):247-55.

PMID:
12581744
3.

[Inhibitation of tumor angiogenesis, growth and metastasis by blocking VEGF paracrine pathway].

Wang F, Tian YH, Li L, Chen XF, Hu HH, Li CY, Huang Q.

Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai). 2002 Mar;34(2):165-70. Chinese.

PMID:
12006990
5.

Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells.

Bachelder RE, Lipscomb EA, Lin X, Wendt MA, Chadborn NH, Eickholt BJ, Mercurio AM.

Cancer Res. 2003 Sep 1;63(17):5230-3.

7.

Blockade of the stromal cell-derived factor-1/CXCR4 axis attenuates in vivo tumor growth by inhibiting angiogenesis in a vascular endothelial growth factor-independent manner.

Guleng B, Tateishi K, Ohta M, Kanai F, Jazag A, Ijichi H, Tanaka Y, Washida M, Morikane K, Fukushima Y, Yamori T, Tsuruo T, Kawabe T, Miyagishi M, Taira K, Sata M, Omata M.

Cancer Res. 2005 Jul 1;65(13):5864-71.

8.

Regulation of endothelial cell branching morphogenesis by endogenous chemokine stromal-derived factor-1.

Salvucci O, Yao L, Villalba S, Sajewicz A, Pittaluga S, Tosato G.

Blood. 2002 Apr 15;99(8):2703-11.

9.

Vascular endothelial cell growth factor (VEGF), an emerging target for cancer chemotherapy.

Shinkaruk S, Bayle M, Laïn G, Déléris G.

Curr Med Chem Anticancer Agents. 2003 Mar;3(2):95-117. Review.

PMID:
12678905
10.
11.
12.

Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.

Kato H, Yoshikawa M, Miyazaki T, Nakajima M, Fukai Y, Masuda N, Fukuchi M, Manda R, Tsukada K, Kuwano H.

Anticancer Res. 2002 Nov-Dec;22(6C):3977-84.

PMID:
12553021
13.

Procollagen I COOH-terminal fragment induces VEGF-A and CXCR4 expression in breast carcinoma cells.

Palmieri D, Astigiano S, Barbieri O, Ferrari N, Marchisio S, Ulivi V, Volta C, Manduca P.

Exp Cell Res. 2008 Jul 1;314(11-12):2289-98. doi: 10.1016/j.yexcr.2008.04.016. Epub 2008 May 10.

PMID:
18570923
14.

In vitro and in vivo angiogenesis in PC12 pheochromocytoma cells is mediated by vascular endothelial growth factor.

Middeke M, Hoffmann S, Hassan I, Wunderlich A, Hofbauer LC, Zielke A.

Exp Clin Endocrinol Diabetes. 2002 Nov;110(8):386-92.

PMID:
12518248
15.

Angiogenic effects of prostaglandin E2 are mediated by up-regulation of CXCR4 on human microvascular endothelial cells.

Salcedo R, Zhang X, Young HA, Michael N, Wasserman K, Ma WH, Martins-Green M, Murphy WJ, Oppenheim JJ.

Blood. 2003 Sep 15;102(6):1966-77. Epub 2003 Jun 5.

16.

Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype.

Issa A, Le TX, Shoushtari AN, Shields JD, Swartz MA.

Cancer Res. 2009 Jan 1;69(1):349-57. doi: 10.1158/0008-5472.CAN-08-1875.

17.

Autocrine-paracrine VEGF loops potentiate the maturation of megakaryocytic precursors through Flt1 receptor.

Casella I, Feccia T, Chelucci C, Samoggia P, Castelli G, Guerriero R, Parolini I, Petrucci E, Pelosi E, Morsilli O, Gabbianelli M, Testa U, Peschle C.

Blood. 2003 Feb 15;101(4):1316-23. Epub 2002 Oct 24.

18.

CXCL12 and vascular endothelial growth factor synergistically induce neoangiogenesis in human ovarian cancers.

Kryczek I, Lange A, Mottram P, Alvarez X, Cheng P, Hogan M, Moons L, Wei S, Zou L, Machelon V, Emilie D, Terrassa M, Lackner A, Curiel TJ, Carmeliet P, Zou W.

Cancer Res. 2005 Jan 15;65(2):465-72.

19.

Involvement of G proteins in vascular permeability factor/vascular endothelial growth factor signaling.

Mukhopadhyay D, Zeng H.

Cold Spring Harb Symp Quant Biol. 2002;67:275-83. No abstract available.

PMID:
12858550
20.

Roles of angiogenic factors and endothelin-1 in gastric ulcer healing.

Akimoto M, Hashimoto H, Maeda A, Shigemoto M, Yamashita K.

Clin Sci (Lond). 2002 Aug;103 Suppl 48:450S-454S.

PMID:
12193143

Supplemental Content

Support Center